These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 194551)

  • 1. Interferon production and response to exogenous interferon in two cell lines of mouse brain origin persistently infected with Sendai virus.
    Collins AR; Flanagan TD
    Arch Virol; 1977; 53(4):313-21. PubMed ID: 194551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon production and virus replication in lymphoblastoid cells infected with different viruses.
    Heremans H; de Ley M; Volckaert-Vervliet G; Billiau A
    Arch Virol; 1980; 63(3-4):317-20. PubMed ID: 6243928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon production and activity in mouse neuroblastoma cells.
    Stohlman SA; Sakaguchi AY; Hiti A
    Arch Virol; 1978; 57(1):91-6. PubMed ID: 207242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of a Sendai virus variant with temperature-sensitive hemolytic activity from persistently infected cells from mouse brain.
    Collins AR; Flanagan TD
    Arch Virol; 1978; 58(2):81-93. PubMed ID: 213044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exogenous interferon on L cells persistently infected with Sendai virus.
    Ito Y; Nishiyama Y; Shimokata K; Maeno K
    Arch Virol; 1984; 80(1):33-45. PubMed ID: 6200093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of L cells persistently infected with VSV: factors involved in the regulation of persistent infection.
    Nishiyama Y
    J Gen Virol; 1977 May; 35(2):265-79. PubMed ID: 195007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon inducibility and sensitivity of human teratocarcinoma-derived cell lines.
    Ogunkolade W; Canivet M; Pochart F; Fourcade A; Chousterman S; Hovanessian A; Peries J
    J Interferon Res; 1987 Jun; 7(3):245-54. PubMed ID: 2440957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of interferon production in a newly established human cell line.
    Toba M; Suzuki H; Sekine N
    Intervirology; 1979; 11(4):221-6. PubMed ID: 218901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.
    Youngner JS; Thacore HR; Kelly ME
    J Virol; 1972 Aug; 10(2):171-8. PubMed ID: 4342236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the sensitivity of different viruses to interferon.
    Hallum JV; Thacore HR; Youngner JS
    J Virol; 1970 Aug; 6(2):156-62. PubMed ID: 4322869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
    Maheshwari RK; Jay FT; Friedman RM
    Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon induction and action in transformed poikilothermic cells.
    Vassileva V; Galabov A
    Acta Microbiol Acad Sci Hung; 1975; 22(3):323-8. PubMed ID: 168742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of the viral genome in interferon-treated cells infected with oncogneic or nononcogenic viruses.
    Friedman RM; Costa JC; Ramseur JM; Meyers MW; Jay FT; Chang EH
    J Infect Dis; 1976 Jun; 133 Suppl():A43-50. PubMed ID: 180209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interferon in murine lactic dehydrogenase virus infection, in vivo and in vitro.
    Dubuy H; Baron S; Uhlendorf C; Johnson ML
    Infect Immun; 1973 Dec; 8(6):977-84. PubMed ID: 4361729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of interferon production to the limited replication of Newcastle disease virus in L cells.
    Nagai Y; Ito Y; Hamaguchi M; Yoshida T; Matsumoto T
    J Gen Virol; 1981 Jul; 55(Pt 1):109-16. PubMed ID: 6170723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses.
    Lundh B; Kristensson K; Norrby E
    Neuropathol Appl Neurobiol; 1987; 13(2):111-22. PubMed ID: 3039392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STUDIES ON PERSISTENT INFECTIONS OF TISSUE CULTURES. V. THE INITIAL STAGES OF INFECTION OF L(MCN) CELLS BY NEWCASTLE DISEASE VIRUS.
    RODRIGUEZ JE; HENLE W
    J Exp Med; 1964 Jan; 119(6):895-921. PubMed ID: 14178459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.